Shanghai Pharmaceuticals Holding Co., Ltd (SHA:601607)

SHA:601607 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 17, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	60,997	69,396	56,107	60,072	49,277	47,493
Market Cap Growth	-5.63%	23.68%	-6.60%	21.91%	3.75%	-0.60%
Enterprise Value	88,394	95,555	80,065	81,075	76,701	71,525
Last Close Price	18.12	20.68	16.07	16.63	18.09	17.06
PE Ratio	11.07	15.24	14.89	10.69	9.68	10.56
Forward PE	14.96	22.41	8.08	14.04	10.35	11.36
PS Ratio	0.22	0.25	0.22	0.26	0.23	0.25
PB Ratio	0.69	0.83	0.70	0.77	0.83	0.87
P/TBV Ratio	1.15	1.26	1.10	1.21	1.54	1.65
P/FCF Ratio	14.63	20.25	24.82	29.18	52.28	12.39
P/OCF Ratio	9.68	11.91	10.73	12.67	9.74	6.94
PEG Ratio	-	0.84	0.84	0.84	0.84	0.84
EV/Sales Ratio	0.32	0.35	0.31	0.35	0.36	0.37
EV/EBITDA Ratio	8.31	9.30	7.94	8.37	8.55	8.15
EV/EBIT Ratio	10.69	10.92	9.33	9.93	10.27	9.82
EV/FCF Ratio	21.20	27.89	35.41	39.39	81.38	18.65
Debt / Equity Ratio	0.69	0.65	0.65	0.57	0.69	0.67
Debt / EBITDA Ratio	5.75	4.97	4.82	4.29	4.24	3.90
Debt / FCF Ratio	14.68	15.95	22.96	21.67	43.25	9.58
Asset Turnover	1.21	1.27	1.27	1.28	1.38	1.34
Inventory Turnover	6.52	6.48	6.45	6.55	7.32	6.77
Quick Ratio	0.99	1.02	0.98	0.99	0.93	0.90
Current Ratio	1.32	1.36	1.33	1.35	1.27	1.22
Return on Equity (ROE)	8.50%	7.16%	6.53%	10.20%	11.03%	10.77%
Return on Assets (ROA)	2.25%	2.52%	2.61%	2.82%	2.99%	3.18%
Return on Capital (ROIC)	3.57%	4.04%	4.21%	4.59%	4.88%	5.19%
Return on Capital Employed (ROCE)	8.40%	9.20%	9.60%	9.30%	10.40%	11.90%
Earnings Yield	9.95%	6.56%	6.72%	9.35%	10.34%	9.47%
FCF Yield	6.83%	4.94%	4.03%	3.43%	1.91%	8.07%
Dividend Yield	1.60%	1.79%	2.55%	3.67%	2.32%	2.81%
Payout Ratio	57.86%	79.16%	105.66%	55.08%	52.54%	53.79%
Buyback Yield / Dilution	-0.09%	-0.07%	-6.28%	-22.54%	-	-
Total Shareholder Return	1.52%	1.71%	-3.72%	-18.87%	2.32%	2.81%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.